Aging and cancer in transgenic and mutant mice

Frontiers in Bioscience

Volumn 8, Issue SUPPL., 2003, Pages

  Anisimov, Vladimir N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

Aging; Cancer; Knockout animals; Mutant animals; Review; Transgenic animals

Indexed keywords

CATALASE; COPPER; DNA METHYLTRANSFERASE; GROWTH HORMONE; INSULIN; PLASMINOGEN ACTIVATOR; SUPEROXIDE DISMUTASE; THIOREDOXIN; UROKINASE;

AGING; CARCINOGENESIS; CELL COMMUNICATION; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; DNA REPAIR; GENE CONTROL; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; NONHUMAN; REVIEW; TRANSGENIC MOUSE; ANIMAL; GENETICS; MOUSE; MOUSE MUTANT; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA; MUS MUSCULUS;

AGING; ANIMALS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASMS;

EID: 4344605785     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1122     Document Type: Review

References (246)

1. de Haan G., R. Gelman, A. Watson, E. Yunis & G.Van Zant, G: A putative gene causes variability in lifespan among genotypically identical mice. Nature Genet 19, 114-116 (1998)
2. Jazwinski S.M.: Commentary on "Application of enxogenously regulatable promoter systems to transgenic models for the study of aging". J Gerontol 54A, B41-B42 (1999)
3. Ingram D.K. & M. Jucker: Developing mouse models of aging: a consideration of strain differences in age-related behavioral and neural parameters. Neurbiol Aging 20, 137-145 (1999)
4. Morgan W.W., A. Richardson, Z.D. Sharp, C.A. Walter: Application of exogenously regulatable promoter systems to transgenic models for the study of aging. J Gerontol 54A, B30-B40 (1999)
5. Guarente L. & C. Kenyon: Genethic pathways that regulate ageing in model organisms. Nature 408, 255-262 (2000)
6. Jazwinski S.M.: Longevity, genes, and aging: aview provided by a genetic model system. Exp Geront 34, 1-6 (1999)
7. Anisimov V.N.: Carcinogenesis and aging. Adv Cancer Res 40, 365-424 (1983)
8. Anisimov VN: Carcinogenesis and Aging. Vols. 1 & 2. CRC Press, Boca Raton (1987)
9. Miller R.A.: Gerontology as oncology. Cancer 68, 2496-2501 (1991)
10. Campisi J.: Aging and cancer: the double-edged sword of replicative senescence. J Am Geriatr Soc 45, 482-488 (1997)
11. Anisimov VN: Age as a risk factor in multistage carcinogenesis. In: Comprehensive Geriatric Oncology. Eds: Balducci L, Lyman, GH, Ershler WB. Harwood Acad.Publ., Amsterdam 157-178 (1998)
12. Anisimov V.N.: Ageing and the mechanisms of carcinogenesis: some practical implications. J Exp Clin Cancer Res 17, 263-268 (1998)
13. Dix D. & P. Cohen: On the role of aging in carcinogenesis. Anticancer Res 19, 723-726 (1999)
14. Campisi J.: Cancer, aging and cellular senescense. In Vitro 14, 183-188 (2000)
15. DePinho R.A.: The age of cancer. Nature 408, 248-254 (2000)
16. Ershler W.B. & E.T. Keller: Ann Rev Med 51, 245-270 (2000)
17. Anisimov V.N.: The relationship between aging and carcinogenesis: a critical appraisal. Crit Rev Oncol Hematol 45, 277-304 (2003)
18. Kinzler K.W. & B. Vogelstein: 1997. Gatekeepers and caretakers. Nature 386, 761-763 (1997)
19. Lengauer C., K.W. Kinzler & B. Vogelstein: Genetic instabilities in human cancers. Nature 396, 643-649 (1998)
20. Hanahan D. & R.A. Weinberg: The hallmarks of cancer. Cell 100, 57-70 (2000)
21. Alexander J.: Use of transgenic mice in identifying chemopreventive agents. Toxicol Lett 112/113, 507-512 (2000)
22. Gulezian D., D. Jacobson-Kram, C.M. McCullough, H. Olson, L. Reico, D. Obinson, R. Storer, R. Tennant, J.M. Ward & D.A. Neumann: Use of transgenic animals for carcinogenicity testing: considerations and imlications for risk assessment. Toxicol Pathol 28, 482-499 (2000)
23. Anisimov V.N.: Mutant and genetically modified mice as models for studying the relationship between aging and carcinogenesis. Mech Ageing Dev122, 1211-1255 (2001)
24. Pendergrass W.R., Y. Li, D. Jiang & N.S. Wolf: Decrease in cellular replicative potential in "giant" mice transfected with the bovine growth hormone gene correlates to shortened life span. J Cell Physiol 156, 96-103 (1993)
25. Steger R.W., A. Bartke &M. Cecim: Premature aging in transgenic mice expressing growth hormone genes. J Repr Fertil Suppl 46, 61-75 (1993)
26. Rollo C.D., J. Carlson & M. Sawada: Accelerated aging of giant transgenic mice is associated with elevated free radical processes. Can J Zool 74, 606-620 (1996)
27. Brown-Borg H.M. & S.G. Rakoczy: Catalase expression in delayed and premature aging mouse models. Exp Gerontol 35, 199-212 (2000)
28. Miller D.B., A. Bartke & J.P. O'Callaghan: Increased glial fibrillary acidic protein (GFAP) levels I the brains of transgenic mice expressing the bovine growth hormone (bGH) gene. Exp Gerontol 30, 383-400 (1995)
29. Meliska C.J., P.A. Burke, A. Bartke & R.A. Jensen: Inhibitory avoidance learning in transgenic mice overexpressing the growth hormone gene. Neurobio Learn Med 68, 1-12 (1997)
30. Naar E.M., A. Bartke, S.S. Majumdar, P.C. Buonomo, J.S. Yun & T.S. Wagner: Fertility of transgenic female mice expressing bovine growth hormone or human growth hormone variant genes. Biol Reprod 45, 178-187 (1991)
31. Steger R.W., A. Bartke, T.A. Parkening, T. Collins, R. Cerven, J.S. Yun & T.E. Wagner: Effect of chronic exposure to bovine growth hormone (bGH) on the hypothalamic-pituitary axis in transgenic mice: Relationship to the degree of expression of the PEPCK.bGH hybrid gene. Transgenics 1, 245-253 (1994)
32. Mayerhofer A., J. Weis, A. Bartke, J.S. Yun & T.E. Wagner: Effects of transgenes for human and bovine growth hormones on age-related changes in ovarian morphology in mice. Anat Rec 227, 175-186 (1990)
33. Wolf E., E. Kahnt & J. Ehrlein: Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: lessons from transgenic animal models. Mech Ageing Dev 68, 71-87 (1993)
34. Bartke A.: Growth hormone and aging. Endocrine 8, 103-108 (1998)
35. Snibson K.J., P.S. Bhatha & C.L. Hardy: High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice. Liver 19, 242-252 (1999)
36. Asa S.L., K. Kovacs, L. Stefaneanu, E. Horvath, N. Billestrup, C. Conzalez Manchon & W. Vale: Pituitary mammosomatotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone. Proc Soc Exp Biol Med 193, 323-325 (1990)
37. Dilman VM: Development, Aging and Disease. A New Rationale for an Intervention Strategy. Harwood Academic Publ, Chur (1994)
38. Kenyon C.: A conserved regulatory system for aging. Cell 105, 165-168 (2001)
39. Ward A., P. Bates, R. Fisher, L. Richardson & C.F. Graham: Disproportionate growth in mice with Igf-2 transgenes. Proc Natl Acad Sci USA 91, 10365-10369 (1994)
40. Takeda T., T. Matushita, M. Kurozumi, K. Takemura, K. Higuchi & M. Hosokawa: Pathobiology of the senescence-accelerated mouse (SAM). Exp Gerontol 32, 117-127 (1997)
41. Takeda T.: Senescence-accelerated mouse (SAM): a biogerontological resource in aging research. Neurobiol Aging 20, 105-110 (1999)
42. Bulygina E., S. Gallant, G. Kramarenko & A.A. Boldyrev: Characterizatin of the age changes in brain and liver enzymes of senescence-accelerated mice. JAAM 2, 43-49 (1999)
43. Choi J.Y., H.S. Kim, H.K. Kang, D.W. Lee, E.M. Choi & M.H. Chung: Thermolabile 8-hydroxyguanine DNA glycosylase with low activity in senescence-accelerated mice due to a single-base mutation. Free Radic Biol Med 27, 848-854 (1999)
44. Yuneva M.O., N.V. Guseva & A.A. Boldyrev: Mice strain SAM as a mode of aging caused by reactive oxygen species. Adv Gerontol 4, 147-152 (2000)
45. Park J.W., C.H. Choi, M.S. Kim & M.H. Chung: Oxidative status in senescence-accelerated mice . J Gerontol Biol Sci Med 51A, B337-345 (1996)
46. Miyamoto H., N. Manabe, Y. Mitani, N. Sugimoto, T. Watanabe, C. Aruga & E. Sato: Female reproductive properties and prenatal development of a senescence-accelerated mouse strain. J Exp Zool 272, 116-122 (1995)
47. Nisitani S., M. Hosokawa, M.S. Sasaki, K. Yasouka, H. Naiki, T. Matsushita & T. Takeda: Acceleration of chromosome aberrations in senescence-accelerated strains of mice. Mutat Res 237, 221-228 (1990)
48. Uryvaeva I.V., T.L. Marschak, S.T. Zakhidov, M.L. Semenova & G.V. Delone: Micronuclear aberrations accumulated with age in liver cells from SAM line mice, aging at an accelerated rate. Dokl Russ Akad Nauk 368, 703-705 (1999)
49. Odagiri Y., H. Uchida, M. Hosokawa, K. Takemota, A.A. Morley &T. Takeda: Accelerated accumulation of somatic mutations in the senescence-accelerated mouse. Nature Genet 19, 116-117 (1998)
50. Hosokawa M., H. Fujisawa, S. Ax, G. Zahn-Daimler & R.K. Zahn: Age-associated DNA damage is accelerated in the senescence-accelerated mice. Mech Ageing Dev 118, 61-70 (2000)
51. Meeker H.C. & R.I. Carp: Titres of murine leukemia virus are higher in brains of SAMP8 than SAMR1 mice. Neurobiol Aging 18, 543-547 (1997)
52. Sugimura Y., M. Sakurai, N. Hayahi, A. Yamashita & J. Kawamura: Age-related changes of the prostate gland in the senescence-accelerated mouse. Prostate 24, 24-32 (1994)
53. Kuro-o M., Y. Matsumura, H. Aizawa, H. Kawaguchi, T. Suga, T. Utsgi, Y. Ohyama, M. Kurabayashi, T. Kaname, E. Kume, H. Iwasaki, A. Iida, T. Shiraki-Iida, S, Nishikawa, R. Nagai & Y. Nabeshima: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45-51 (1997)
54. Mori K., K. Yahata, M. Mukoyama, T. Sugunami, H. Makino, T. Nagae, H. Masuzaki, Y. Ogawa, A. Sugawara, Y. Nabeshima & K. Nakao: Disruption of klotho gene causes an abnormal energy homeostasis in mice. Biochmem. Biophys. Res Commun 278, 665-670 (2000)
55. Utsugi T., T. Ohno, Y. Ohyama, T. Uchiyama, Y. Saito, Y. Matsumura, H. Aizawa, H. Itoh, M. Kurabayashi, S. Kawazu, S. Tomono, Y. Oka, T. Suga, M. Kuro-o, Y. Nabeshima & R. Nagai:. Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging. Metabolism 49, 1118-1123 (2000)
56. Ito S., S. Kinoshita, N. Hiraishi, S. Nakagawa, S. Sekie, T. Fujimori & Y. Nabeshima: Molecular cloning and expression analyses of mouse ßklotho, which encodes a novel Klotho family protein. Mech Dev 98, 115-119 (2000)
57. Kashimada K., T. Yamashita, K. Tsuji, A. Nifuji, S. Mizutani, Y. Nabeshima and M. Noda: Defects in growth ad bone metabolism in klotho mutant mice are resistant to GH treatment. J Endocrinol 174, 403-410 (2002)
58. Kawaguchi H., N. Manabe, C. Miyaura, H. Chikuda, K. Nakamura & M. Kuro-o: Independent impairment of osteoblasts and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia. J Clin Invest 104, 229-237 (1999)
59. Arking D.E., A. Krebsova, M. Macek, M. Macek, A. Akring, L. Fried, A. Hamosh, S. Dey, I. McIntosh & H.C. Dietz: Association of human aging with a functional variant of klotho. Proc Natl Acad Sci USA 99, 856-861 (2002)
60. Kawano K., N. Ogata, M. Chiano, H. Molloy, P. Kleyn, T.D. Spector, M. Uchida, T. Hosoi, T. Suzuki, H. Orimo, S. Inoue, Y. Nabeshima, K. Nakamura, M. Kuro-o & H. Kawaguchi: Klotho gene polymorphysms associated with bone density of aged postmenopausal women. J Bone Miner Res 17, 1744-1751 (2002)
61. Bernstein C & H Bernstein: Aging, Sex, and DNA Repair. Academic Press, San Diego (1991)
62. Vijg J.: Somatic mutations and aging: a re-evaluation. Mutat Res 447, 117-135 (2000)
63. Benhamou S. & A. Sarasin: Variability in nucleotide excision repair and cancer risk: a review. Mutat Res 462, 149-158 (2000)
64. de Boer J., G.T. van der Horst & K.H. Hoeijmakers: Mutant mice as a model of human diseases of aging. Defective transcription and premature aging. Tijdscr Gerontol Geriatr 30, 168-170 (1999)
65. de Boer J., J.O. Andressoo, J. de Wit, J. Hujmans, R.B. Beems, H. van Steeg, G. Weeda, G.T.J. van der Horst, W. van Leeuwen, A.P.N. Themmen, M. Meradji & J.H. Hoeijmakers: Premature aging in mice deficient in DNA repair and transcription. Science 296, 1276-1279 (2002)
66. Lehmann A.: Ageing: repair and transcription keep us from premature aging. Curr Biol 12, R550-R551 (2002)
67. Harada Y.N., N. Shiomi, M. Koike, M. Ikawa, M. Okabe, S. Hirota, Y. Kitamura, M. Kitagawa, T. Matsunaga, O. Nikaido & T. Shiomi: Postnatal growth failure, short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene. Mol Cell Biol 19, 2366-2372 (1999)
68. Van Steeg H., H. Klein, R.B. Beems, C.F. van Kreijl: Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing. Toxicol Pathol 26, 742-749 (1998)
69. Van Steeg H., L.H.F. Mullenders & J. Vijg: Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice. Mutat Res 450, 167-180 (2000)
70. Gos K.H., M.A. Risinger, J. Kordich, M.M. Sanz, J.E. Straughen, L.E. Slovek, J. German, G.P. Boivin & J. Groden: Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297, 2051-2053 (2002)
71. Ruscetti T., B.E. Lehnert, J. Halbrook, H. Le Trong, M.F. Hoekstra, J. Chen & S.R. Peterson: Stimulation of the DNA-dependent protein kinase by poly(ADP-ribose) polymerase. J Biol Chem 273, 14461-14467 (1998)
72. Dantzer F., V. Schreiber, C. Nidergag, C. Trucco, E. Flatter, G. De La Rubia, J. Oliver, V. Rolli, J. Menisser-de Murcia & G. de Murcia: Involvement of poly(ADP-ribose) polymerase in base excision repair. Biochimie 81, 69-75 (1999)
73. Berger N.A., J.L. Sim, D.M. Catino & S.J. Berger: Poly(ADP-ribose) mediates the suicide response to massive DNA damage: studies in normal and DNA repair defective cells. In: ADP-ribolysation, DNA Repair, and Cancer. Eds: Miva M, Hayashi O, Shall S, Smulson M, Sugimura T, Jpn Sci Soc Press 219-226 Tokyo, Japan (1983)
74. Burkle: Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays 23, 795-806 (2001)
75. Masutani M., T. Nozaki, K. Nakamoto, H. Nakagama, H. Suzuki, O. Kusuoka, M. Tstsumi & T. Sugimura: The reponse of Rarp knockout mice against DNA damaging agents. Mutat Res 462, 159-166 (2000)
76. Vogel H., D.-S. Lim, G. Karsenty, M. Finegold & P. Hasty: Deletion of Ku80 causes early onset of senescence in mice. Proc Natl Acad Sci USA 96, 10770-10775 (1999)
77. Difilippantonio M.J., J. Zhu, H.T. Cheng, E. Meffre, M.C. Nussenzweig, E.E.Max, T. Ried & A. Nussenzweig: DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404, 510-514 (2000)
78. Gu Y., K.J. Seidi, G.A. Rathbun, C. Zhu, J.P. Manis, N. van der Stoep, L. Davidson, H.L. Cheng, J.M. Sekiguchi, K. Frank, P. Stanhope, P. Baker, M.S. Schlissel, D.B.Roth & F.W. Alt: Growth retardation and leakey SCID phenotype of Ku70-deficient mice. Immunity 7, 653-665 (1997).
79. Li G.C., H. Ouyang, X. Li, H. Nagasawa, J.B. Little, D.J. Chen, C.C. Ling, Z. Fuks & C. Cordon Cardo: Ku70: a candidate tumor suppressor gene for murine T cell lymphoma. Mol. Cell 2, 1-8 (1998)
80. Levine A.J.: p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997)
81. Jacks T., L. Remington, B.O. Williams, E.M. Schmitt, S. Halachmi, R.T. Bronson & R.A. Weinberg: Tumor spectrum analysis in p53-mutat mice. Cure Biol 4, 1-7 (1997)
82. Finkel T. & N.J. Holbrook: Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247 (2000)
83. Sohal R.S.: Role of oxidative stress and protein oxidation in the aging process. Free Radical Biol Med 33, 37-44 (2002)
84. Wallace D.C.: Animal models for mitochondrial disease. Methods Mol Biol 197, 3-54 (2002)
85. Nabarra B., M. Casanova, D. Paris, E. Paly, K. Toyoma, I. Ceballos & J. London: Premature thymic involution, observed at the ultrastructural level, in two lineages of human-SOD-1 transgenic mice. Mech Ageing Dev 96, 59-73 (1997)
86. Cebalos Picot I.: Transgenic mice overexpressing copper-zinc superoxide dismutase: a model for the study of radical mechanisms and aging. CR Seances Soc Biol Fil 187, 308-323 (1993)
87. Cardozo Pelaez F., S. Song, A. Parthasarathy, C.J. Epstein & J. Sanchez Ramos: Attenuation of age-dependent oxidative damage to DNA and protein in brainstem of Tg Cu/Zn SOD mice. Neurobiol Aging 19, 311-316 (1998)
88. Gallagher I.M., P. Jenner, V. Glover & A. Clow: Cu,Zn-superoxide dismutase transgenic mice: no effect on longevity, locomotor activity and 3H-azindol and 3H-spiperone binding over 19 months. Neurosci Lett 289, 221-223 (2000)
89. Schriner S.E., C.E. Ogburn, A.C. Smith, T.G. Newcomb, W.C. Ladiges, M.E.T. Dolle, J. Vijg, K.-I. Fukuchi & G.M.Martin: Levels of DNA damage are unaltered in mice overexpressing human catalase in nuclei. Free Radical Biol Med 29, 664-673 (2000)
90. Klungland A., I. Rosewell, S. Hollenbach, E. Larse, G. Daly, B. Epe, E. Seeberg, T. Lindahl & D.E. Barnes: Accumuation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci USA 96, 13300-13305 (1999)
91. Remarque E.: T-cell immunosenescence and its clinical relevance in man. Rev Clin Gerontol 8, 5-14 (1998)
92. th ed., Ed: Paul WE, Lippincott-Raven Publ, Philadelphia 974-965 (1999)
93. Lau L.L. & L.M. Spain: Altered aging-related thymic involution in T cell receptor transgenic, MHC-deficient, and CD4-deficient mice. Mech Ageng Dev 111, 101-121 (1998)
94. Freisleben H.J., F. Lehr & J. Fuchs: Lifespan of immunosuppressed NMRI-mice is increased by deprenyl. J Neural Transm Suppl 41, 231-236 (1994)
95. Freisleben H.J., A. Neeb, F. Lehr & H. Ackermann: Influence of selegiline and lipoic acid on the life expectancy of immunosuppressed mice. Arzneimittelforschung 47, 776-780 (1997)
96. Sharkey F.E. & J. Fogh: Incidence and pathological features of spontaneous tumors in athymic nude mice. Cancer Res 39, 833-839 (1979)
97. Stutman O.: Spontaneous tumors in nude mice: effect of the viable yellow gene. Exp Cell Biol. 47, 129-135 (1979)
98. Shisa H., A. Kojima & H. Hiai: Accelerating effect of nude gene heterozygocity on spontaneous AKR thymic lymphomagenesis. Jpn J Cancer Res 77, 568-571 (1986)
99. Zhou T., C.K. Edwards & J.D. Mountz: Prevention of age-related T-apoptosis defect in CD2-fas-transgenic mice. J Exp Med 182, 129-137 (1995)
100. Siegel R.M., M. Katsumata, T. Miyashita, D.C. Louie, M.I. Greene & J.C, Reed:, 1992. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc Natl Acad Sci USA 89, 7003-7007 (1992)
101. Moroy T., P.E. Fischer, G. Lee, P. Achacoso, F. Wiener & F.W. Alt: High frequency of myelomonocytic tumors in aging E-mu L-myc transgenic mice. J Exp Med 175, 313-322 (1992)
102. Moechars D., K. Lorent, B. De Strooper, L. Dewachter & F. Van Leuven: Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J 15, 1265-1274 (1996)
103. Moechars D., K. Lorent & F. Van Leuven: Premature death in transgenic mice that overexpress a mutant amyloid precursor protein preceded by severe neurodegeneration and apoptosis. Neuroscience 91, 819-830 (1999)
104. Geula C., C.K. Wu, D. Saroff, A. Lorenzo, M.Yuan & B.A.Yankner: Aging renders the brain vulnerable to amyloid beta-rotein neurotoxicity. Nature Med 4, 827-831 (1998)
105. Shoji M., T. Kwarabayashi, M. Sato, A. Sasaki, T.C. Saido, E. Matsubar, Y. Tomidokoro, M. Kanai, M. Shizuka, K. Ishiguro, M. Ikeda, Y. Harigaya, K. Okamoto & S. Hirai: Age-related amyloid beta protein accumulation induces cellular death and macrophage activation in transgenic mice. J Pathol 191, 93-101 (2000)
106. Hsiao K.K., D.R. Bochelt, K. Olson, R. Johannsdottir, C. Kitt, W. Yunis, S. Xu, C. Eckman, S. Younkin & D. Price: Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203-1218 (1995)
107. Chapman P.F., G.L. White, M.W. Jones, D. Cooper Blacketer, Y. Marsall, M. Irizarry, L. Younkin, M.A. Good, T.V., Bliss, B.T. Hyman, S.G. Younkin & K.K. Hsiao: Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nature Neurosci 2, 271-276 (1999)
108. Yang F., K. Ueda, P. Chen, K.H. Ashe & G.M. Cole:. Plaque-associated α-synuclin (NACP) pathology in aged transgenic mice expressing amyloid precursor protein. Brain Res 853, 381-383 (2000)
109. Whytaker Azmitia P.M., M. Wingate, A. Borella, R. Gerlai, J. Rode & E.C. Azmitia: Transgenic mice overexpressing the neurotrophic factor S-100β show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res 776, 51-60 (1997)
110. Pedersen W.A. & M.P. Mattson: No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice. Brain Res 833, 117-120 (1999)
111. Sun W., H. Funakoshi & T. Nakamura T: Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Nerosci 22, 6537-6548 (2002)
112. Barlow C., S. Hirotsune, R. Paylor, M. Liyange, M. Echkaus, F. Collins, Y. Shiloh, J.N. Crawley, T. Reid, D. Tagle & B.A. Wynshaw: Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159-171 (1996)
113. Elson A., Y. Wang, C.J. Daugherty, C.C. Morton, F. Zhou, J. Campos Torres & P.Leder. Pleiotropic defects in ataxia-telangiectasia protein-deficicent mice. Proc Nat Acad Sci USA 93, 13084-13089 (1996)
114. Eilam R., Y. Peter, A. Elson, G. Rotman, Y. Hiloh, Y. Groner & M. Segal: Elective loss of dopaminergic nigrostriatal neurons in brains of Atm-deficient mice. Proc Nat Acad Sci USA 95, 12653-12656 (1998)
115. Spring K., F. Ahangari, S.P. Scott, P. Waring, D.M. Purdie, P.C. Chen, K. Hourigan, J. Ramsay, P.J. McKinnon, M. Swift & M.F. Lavin: Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nature Genet 32, 185-190 (2002)
116. Bond J., M. Haughton, J. Blaydes, V. Gire, D. Wynford-Thomas & F. Wylle: Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene 13, 2097-2104 (1996)
117. Bringold F. & M. Serrano: Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 35, 317-329 (2000)
118. Goodwin E.C., E. Yang, C.-J. Lee, H.-W. Lee, D. DiMaio, E.S. Hwang: Rapid induction of senescence in human cervical carcinoma cells. Proc Natl Acad Sci USA 97, 10978-10983 (2000)
119. Colman M.S., C.A. Afshari & J.C. Barrett:. Regulation of p53 stability and activity in response to genotoxic stress. Mutat. Res. 462, 179-188 (2000)
120. Nishino H., A. Knoll, V.L. Buettner, C.S. Frisk, Y. Maruta, J. Haavik & S.S. Sommer. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain. Oncogene 11, 263-270 (1995)
121. Buettner V.L., H. Nishino, J. Haavik, A. Knoll, K. Hill & S.S. Sommer: Spontaneous mutationfrequencies and spectra in p53 (+/+) and p53(-/-) mice: a test of the 'guardian of the genome' hypothesis in th Big Blue transgenic mouse mutation detection system. Mutat Res 379, 13-20 (1997)
122. Donehower L.A., M. Harvey, H. Vogel, M.J. McArthur, C.A. Montgomery, S.H. Park, T. Thompsom, R.J. Ford & A. Bradley: Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinogenesis 14, 16-22 (1995)
123. Donehower L.A., M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery, J.S.Butel & A. Bradley: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356, 215-221 (1992)
124. Hursting S.D., S.N. Perkins, D.C. Haies, J.M. Ward & J.M. Phang: Chemoprevention of spontaneous tumorigenesis in p53-knockout mice. Cancer Res 55, 3949-3953 (1995)
125. Perkins S.N., S.D. Hursting, D.S. Haines, S.J. James, B.J. Miller & J.M. Phang: Chemopre-vention of spontaneous tumorigenesis in nullyzygous p53-deficient mice by dehydroepiandro-sterone and its analog 16-alpha-fluoro-5-androsten-17-one. Carcinogenesis 18, 989-994 (1997)
126. Atardi L.D. & T. Jacks: The role of p53 in tumour suppression: lessons from mouse models. Cell Mol Life Sci 55, 48-63 (1999)
127. Artandi S.E., S. Chang, L. Lee, S. Alson, G.J. Gottlieb, L. Chin & R.A. DePinho: Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641-645 (2000)
128. Finch G.L., T.H. March, F.F. Hahn, E.B. Barr, S.A. Belinsky, M.D. Hoover, J.F. Lechner, K.J. Nikula & C.H. Hobbs: Carcinogenic responses of transgenic heterozygous p53 knockout mice to inhaled 239PuO2 or metallic beryllium. Toxicol Pathol 26, 484-491 (1998)
129. Tsukada K. Ohkusu, T. Tsukada & K. Isobe: Accelerated development and aging of the immune system in p53-deficient mice. J Immunol 163, 1966-1972 (1999)
130. Harvey M., H. Vogel, E.Y. Lee, A. Bradley & L.A. Donehower: Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 55, 1146-1151 (1995)
131. Dass S.B., T.J. Bucci, R.H. Heflic & D.A. Casciano: Evaluation of the trangenic p53+/- mouse for detecting genotoxic liver carcinogens in a short-term bioassay. Cancer Lett 143, 81-85 (1999)
132. Spadling J.W., J.E. French, S. Stasiewicz, M. Furedi Machacek, F. Conner, R.R. Tice & R.W. Tennant: Responses of transgenic mouse lines p53(+/-) and Tg.AC to agents tested in conventional carcinogenicity bioassays. Toxicol Sci 53, 213-223 (2000)
133. Sukata T., Ozaki, K., Uwagara, S., Seki, T., Wanibuchi, H., Yamamoto, S., Okuno, Y., Fukushima, S., 2000. Organ-specific, carcinogen-induced increases in cell proliferation in p53-defecient mice. Cancer Res. 60, 74-79.
134. Yang A., N. Walker, R. Bronson, M. Kaghad, M. Oosterwegel, J. Bonnin, C. Vagner, H. Bonnet, P. Dikkes, A. Sharpe, F. McKeon & D. Caput: p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404, 99-103 (2000)
135. Storer J.B.: Longevity and gross pathology at death in 22 inbred mouse strains. J Gerontol 21, 404-409 (1966)
136. Tyner S.D., S. Venkatachalam, J. Choi, S. Jones, N. Ghebranious, H. Igelmann, X. Lu, G. Soron, B. Cooper, C. Brayton, S.H. Park, T. Thompson, G. Karsenty, A. Bradley & L.A. Donehower: p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45-53 (2002)
137. Serrano M., A.W. Lin, M.E. McGurrach, D. Beach & S.W. Lowe: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16 INK4a. Cell 88, 593-602 (1997)
138. Itahana, G. Dimri & J. Campisi:. Regulation of cellular senescence by p53. Eur J Biochem 268, 2784-2791 (2001)
139. Ferbeyre G. & S.W. Lowe: Ageing: the price of tumor suppression? Nature 415, 26-27 (2002)
140. Skulachev V.P.: The programmed death phenomena, aging, and the Samurai law of biology. Exp Gerontol 36, 995-1024 (2001)
141. Trosko J.E., C.C. Chang, M.R. Wilson, B. Upham & T. Hayashi: Gap junctions and regulation of cellular functions of stem cells during development and differentiation. Methods 20, 245-264 (2000)
142. Yamasaki H., V. Krutovskikh, M. Mesnil, T. Tanaka, M.L. Zaidan Dagli & Y. Omori: Role of connexin (gap junction) genes in cell growth control and carcinogenesis. CR Acad Sci III 322, 151-159 (1999)
143. Xie H.Q. & V.W. Hu: Modulation of gap junctions in senescent endothelial cells. Exp Cell Res 214, 172-176 (1994)
144. Scherer S.S., Y.T. Xu, E. Nelles, K. Fishbeck, K. Willecke & L.J. Bone: Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 24, 8-20 (1998)
145. Modjanova E.A., O.A. Bocahrova & A.G. Malenkov: A system of tissue integration and predisposition to spontaneous tumors. IARC Sci Publ 51, 135-142 (1983)
146. Temme A., A. Buchmann, H.D. Gabriel, E. Nelles, M. Schwarz & K. Willecke: High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol 7, 713-716 (1997)
147. Cerni C.: Telomere, telomerase, and myc. An update. Mutat Res 462, 31-47 (2000)
148. Goyns M.H. & W.L. Lavery: Telomerase and mammalian ageing: a critical appraisal. Mech Ageing Dev 114, 69-77 (2000)
149. Ishikawa F.: Aging clock: the watchmaker's masterpiece. Cell Mol Life Sci 57, 698-704 (2000)
150. Blasco M.: Telomerase beyond telomeres. Nature Rev Cancer 2, 627-633 (2002)
151. Bodnar A.G., M. Ouellette, M. Frolkis, S.E. Holt, C.P. Chiu, G.B. Morin, C.B. Harley, J.W. Shay, S. Lichtsteiner & W.E. Wright: Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998)
152. Jiang X.R., G. Jimenez, E. Chang, M. Frolkis, B. Kusler, M. Sage, M. Beche, A.G. Bodnar, G.M. Wahl, T.D. Tlsty & C.P. Chiu: Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nature Genet 21, 111-114 (1999)
153. Morales C.P., S.E. Holt, M. Ouellette, K.J. Kaur, Y. Yan, K.S. Wilson, M.A. White, W.E. Wright & J.W. Shay: Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genet 21, 115-118 (1999)
154. Yang J., E. Chang, A.M. Cherry, C.D. Bangs, Y. Oei, A. Bodnar, A. Bronstein, C.P. Chiu & G.S. Herron: Human endothelial cell life extension by telomerase expression. J Biol Chem 274, 26141-26148 (1999)
155. Dickson M.A., W.C. Hah, Y. Ino, V. Ronfard, J.Y. Wu, R.A. Weinberg, D.N. Louis, F.P. Li & G.G. Rheinwald: Human kerationcytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20, 1436-1447 (2000)
156. Kiyono T., S.A. Foster, J.I. Koop, J.K. McDougall, D.A. Galloway & A.J. Klingelhutz: Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cels. Nature 396, 84-88 (1998)
157. Wang J., L.Y. Xie, S. Allan, D. Beach & G.J. Hannon: Myc activates telomerase. Genes Dev 12, 1769-1774 (1998)
158. Wang J., G.J. Hannon & D.H. Beach: Risky immortalization by telomerase. Nature 405, 755-756 (2000)
159. Hahn W.C., C.M. Counter, A.S. Lundberg, R.L. Beijersbergen, M.W. Brooks & R.A. Weinberg: Creation of human tumour cells with defined genetic elements. Nature 400, 464-468 (1999)
160. Reddel R.R.: A reassessment of the telomere hypothesis of senescence. Bioessays 20, 977-984 (1998)
161. Wynford-Thomas D.: Cellular senescence and cancer. J Pathol 187, 100-111 (1999)
162. Kipling D. & R.G.A. Faragher: Ageing hard or hardly ageing? Nature 398, 191-192 (1999)
163. Herrera E., E. Samper, J. Martin Caballero, J.M Flores, H.W. Lee & M.A. Blasco: Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 18, 2950-2960 (1999)
164. Lee H.W., M.A. Blasco, G.J. Gottlieb, J.W. Horner, C.W. Greider & R.A. DePinho: Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574 (1998)
165. Rudolph K.L., S. Chang, H.W. Lee, M. Blasco, G.J. Gottlieb, C. Greider & R.A. DePinho: Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712 (1999)
166. Blasco M.A., H.W. Lee, M.P. Hande, E. Samper, P.M. Lansdorp, R.A. DePinho & C.W. Greider: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34 (1997)
167. Chin L., S.E. Artandi, Q. Shen, A. Tam, S.L. Lee, G.J. Gottlieb, C.W. Greider & R.A. DePinho: p53 deficiency rescues the adverse effectsof telomere loss and cooerates with telomere dysfunction to accelrate carcinogenesis. Cell 97, 527-538 (1999)
168. Greenberg R.A., L. Chin, A. Femino, K.H. Lee, G.J. Gottlieb, R.H. Singer, C.W. Greider & R.A. DePinho: Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 97, 515-525 (1999)
169. Gonzalez-Suarez E., E. Samper, J.M. Flores & M.A. Blasco: Teomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nature Genet 26, 114-117 (2000)
170. Artandi S.E. & R.A. DePinho: Mice without telomerase: what can they teach us about human cancer? Nature Med 6, 852-855 (2000)
171. Samper E., J.M. Flores & M.A. Blasco: Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres. EMBO Reports 2, 800-807 (2001)
172. Gonzalez-Suarez E., J.M. Flores & M.A. Blasco: Cooperation between p53 mutation and hih telomerase transgenic expression in spontaneous cancer development. Mol Cell Biol 22, 7291-7301 (2002)
173. Andrechek E.R., W.R. Hardy, P.M. Siegel, M.A. Rudnicki & R.D. Cardiff: Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci USA 97, 3444-3449 (2000)
174. Stocklin E., F. Botteri & B. Groner: An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice. J Cell Biol 122, 199-208 (1993)
175. Baturin D.A., I.N. Alimova, V.N. Anisimov, I.G. Popovich, M.A. Zabezhinski, M. Provinciali, R. Mancini & C. Franceschi: The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a down regulation of HER-2/neu gene expression. Neuroendocrin Lett 22, 439-445 (2001)
176. Mahler J.F., W. Stokes, P.C. Mann, M. Takaoka & R.R. Maronport: Spontaneous lesions in aging FVB/N mice. Toxicol Pathol 24, 710-716 (1996)
177. Stevenson L.E. & A.R. Fracjelton: Constitutively tyrosine phosphorylated p52Shc in breast cancer cells: correlation with ErbB2 and p66Sch expression. Breast Cancer Res Treat 49, 119-128 (1998)
178. Young M.W. & S.A. Kay: Time zones: a comparative genetics of circadian clocks. Nature Rev Genetics 2, 702-715 (2001)
179. Burns E.R.: Biological time and in vivo research: a field guide to pitfalls. The Anat Rec (New Anat) 261, 141-152 (2000)
180. Reppert S.M. & D.R. Weaver: Coordination of circadian timing in mammals. Nature 418, 935-941 (2002)
181. Haus E., G. Nicolau, D.J. Lakatua, L. Sackett-Lundeen & E. Petrescu: Circadian rythm parameters of endocrine functions in elderly subjects during the seventh to the ninth decade of life. Chronobiologia 16, 331-352 (1989).
182. Duffy P.H. & R.J. Feuers: Biomarkers of aging: changes in circadian rhythms related to the modulation of metabolic output. Biomed Environ Sci 4, 182-191 (1991)
183. Hurd M.W. & M.R. Ralph: The significance of ciradian organization for longevity in the golden hamster. J Biol Rhythms 13, 430-436 (1998)
184. Penev P.D., D.E. Kolker, P.C. Zee & F.W. Turek: Chronic circadian desynchronization decreases the survival of animals with cardiomyopathic heart disease. Am J Physiol. 275 (Heart Circ Physiol 44), H2334-H2337 (1998).
185. Fu L., H. Pelicano, J. Liu, P. Huang & C.C. Lee: The circadian gene Period2 plays an important role in tumor suppression and DNA dmage response in vivo. Cell 111, 41-50 (2002)
186. Mattison J.M.: Ames dwarf mice: a model for delayed aging. Adv Gerontol 4, 141-146 (2000)
187. Bartke A., H. Brown-Borg, J. Mattison, B. Kinney, S. Hauck & C. Wright: Prolonged longevity of hypopituitary mice. Exp Gerontol 36, 21-28 (2001)
188. Brown-Borg H.M., K.E. Borg, C.J. Meliska & A. Bartke: Dwarf mice and the aging process. Nature 384, 33 (1996)
189. Duquesnoy R.L.: Immunodeficiency of the thymus-dependent system of the Ames dwarf mouse. J Immunol 108, 1578-1589 (1972)
190. Esquifino A.I., M.A. Villanua, A. Szary, J. Yau & A. Bartke: Ectopic pituitary transplants restore immunocompetence in Ames dwarf mice. Acta Endocrinol 125, 67-72 (1991)
191. Brown Borg H.M., A.M. Bode & A. Bartke: Antioxidative mechanisms and plasma growth hormone levels: potential relationship in the aging process. Endocrine 11, 41-48 (1999)
192. Mattison J.M., C. Wright, R.T. Bronson, G.S. Roth, D.K. Ingram & A. Bartke: Studies of aging in Ames dwarf mice: effects of caloric restriction. J Amer Aging Assoc 23, 9-16 (2000)
193. Zhou Y., B.C. Xu, H.G. Maheshwari, L. He, M. Reed, M. Lozykowski, S. Okada, L. Cataldo, K. Coschigamo, T.E. Wagner, C. Baumann & J.J. Kopchik: A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94, 13215-13220 (1997)
194. Sjorgen K., Y.M. Bohlooly, B. Ollsson, K. Coschigano, J. Tornell, S. Mohan, O.G.P. Isaksson, G. Baumann, J. Kopchick & C. Ohlsson: Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor -/- mice. Biochem Biophys Res Commun 267, 603-608 (2000)
195. Kopchik J.J. & Z. Laron: Is the Laron mouse an accurate model of Laron Syndrome? Mol Genet Metab 68, 232-236 (1999)
196. Coschigano K.T., D. Clemmons, L.L. Bellush & J.J. Kopchick: Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141, 2608-2613 (2000)
197. K.D. Kimura, H.A. Tissenbaum, Y. Liu & G. Ruvkun: daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277, 942-946 (1997)
198. Wolkov, K.D. Kimura, M.S. Lee & G. Ruvkun: Regulation of C. elegans life-span by insulin-like signalling in the nervous system. Nat C.A. Genetics 290, 147-150 (2000)
199. Kenyon C.: A conserved regulatory system for aging. Cell 105, 165-168 (2001)
200. Clancy D.J., D. Gems, L.G. Harshman, S. Oldham, H. Stocker, E. Hafen, S.J. Leevers & L. Partridge: Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292, 104-106 (2001)
201. Tatar M., A. Kopelman, D. Epstein, M.P. Tu, C.M. Yin & R.S. Garofalo: A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292, 107-110 (2001)
202. Dillin A., D.K. Crawford & C. Kenyon: Timing requirements for insulin/IGF-1 signaling in C. elegans. Science 298, 830-834 (2002)
203. Ramaswamy S., N. Nakamura, I. Sansal, L. Bergeron & W.R. Sellers: A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2, 81-91 (2002)
204. Richards J.S., S.C. Sharma, A.E. Falender & Y.H. Lo: Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-1, estrogens, and the gonadotropins. Mol Endocrinol 16, 590-599 (2002)
205. Lupu F., J.D. Terwilliger, K. Lee, G.V. Segre & A Efstratiadis: Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229, 141-162 (2001)
206. Flurkey K., J. Papaconstantinou, R.A. Miller & D.E. Harrison: Life-span extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA 98, 6736-6741 (2001)
207. Bartke A. & D. Turyn: Mechanisms of prolonged longevity: mutants, knock-outs, and caloric restriction. J Anti-Aging Med 4, 197-203 (2001)
208. Weindruch R. & R.S. Sohal: Caloric intake and aging. The New Engl J Med 337, 986-994 (1997)
209. Roth G.S., D.K. Ingram & M.A. Lane: Calorie restriction in primates: will it work and how will we know? J Am Geriatr Soc 46, 869-903 (1999)
210. Barzilai N. & G. Gupta: Interaction between aging and syndrome X: new insights on the pathophysiology of fat distribution. Ann N Y Acad Sci 892, 58-72 (1999)
211. Dominici F.P., G. Arosegui Diaz, A. Bartke, J.J. Kopchik & D. Turyn: Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice. J Endocrinol 166, 579-590 (2000)
212. Dominici F.P., S. Hauck, D.P. Argention, A. Bartke & D. Turyn: Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (ISR)-1 and IRS-2 in liver of Ames dwarf mice. J Endocrinol 173, 81-94 (2002)
213. Holzenberger M., J. Dupond, B. Ducos, P. Leneuve, A. Gefoen, P.C. Even, P. Cervera & Y. Le Bouc: IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182-187 (2003)
214. Bluher M., B.B. Kahn & C.R. Kahn Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299, 572-574 (2003)
215. Bluher M., M.D. Michael, O.D. Peroni, K. Ueki, N. Carter, B.B. Kahn & C.R. Kahn: Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3, 25-38 (2002)
216. Dilman V.M. & V.N. Anisimov: Effect of treatment with phenofromin, dyphenylhydantoin or L-DOPA on life span and tumor incidence in C3H/Sn mice. Gerontology 26, 241-245 (1980)
217. Luzi L., S. Confalonieri, P.P. Di Fiore & P.G. Pelicci: Evolution of Sch functions from nematode to humans. Curr Opin Genet Dev 10, 668-674 (2000)
218. shr adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309-313 (1999)
219. shc protein: A mediator of the programmed death of an organism. IUBMB Life 49, 177-180 (2000)
220. 6-alkylguanine by alkyltransferases. Mutat Res 462, 83-100 (2000)
221. Walter C.A., D.T. Grabowski, K.A. Street, C.C. Conrad & A. Richardson: Analysis and modulation of DNA repair in aging. Mech. Ageing Dev. 98, 203-222 (1997)
222. 6- methylguanine-DNA methyltransferase. Jpn J Cancer Res 91, 1085-1089 (2000)
223. 6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea. Oncogene 18, 3783-3787 (1999)
224. Glassner B.J., G. Weeda, J.M. Allan, J.L. Broekhof, N.H. Carls, I. Donker, B.P. Engelward, R.J. Hampson, R. Hersmus, M.J. Hickman, R.B. Roth, H.B.Warre, M.M. Wu, J.H. Hoeijmakers & L.D. Samson: DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis 14, 339-347 (1999)
225. Mitsui A., J. Hamuro, H. Nakamura, N. Kondo, Y. Hirabayashi, S. Ishizaki-Koizumi, T. Hirakawa, T. Inoue & J. Yodoi: Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal 4, 693-696 (2002)
226. Miskin R. & T. Masos: Transgenic mice overexpressing urokinase-type plasminogen activator in the brain exhibit reduced food consumption, body weight and size, and increased longevity. J Geronlol Biol Sci 52A, B118-6124 (1997)
227. Miskin R., T. Masos, S. Yahav, D. Shinder & A. Globerson: αMUPA mice: a transgenic model for increased life span. Neurobiol Aging 20, 555-564 (1999)
228. Weindruch R. & R. Walford: The Retardation of Aging and Disease by Dietary Restriction. C.C. Thomas, Springfield, Ill (1988)
229. Anisimov V.N.: Life span extension and cancer risk: myths and reality. Exp Gerontol 36, 1101-1136 (2001)
230. Smith G.S., R.L. Walford & H.R. Mickey: Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F1 hybrids. J Natl Cancer Inst 50, 1195-1213 (1973)
231. Anisimov V.N.:. Spontaneous tumors in rats of different strains. Vopr Onkol 8, 98-110 (1976)
232. Staats J.: Standardized nomenclature for inbred strains of mice: seventh listing. Cancer Res 40, 2083-2128 (1980)
233. Boerrigter M.E.T.I., J.Y. Wei & J. Vijg: Induction and repir of benzo(a)pyrene-DNA adducts in C57BL/6 and BALB/c mice: association with aging and longevity. Mech Ageing Dev 82, 31-50 (1995)
234. Pour P., J. Althoff, S.Z. Salmasi & K. Stepan: Spontaneous tumors and common diseases in three types of hamsters. J Natl Cancer Inst 63, 797-811 (1979).
235. Turker M.S.: Estimation of mutation frequencies in normal mammalian cells and the development of cancer. Semin Cancer Biol 8, 407-419 (1998)
236. Holliday R.: Somatic mutations and aging. Mutat Res 463, 173-178 (2000)
237. Crowley C. & H.J. Curtis: The development of somatic mutations in mice with age. Proc Natl Acad Sci USA 49, 625-628 (1963)
238. Sato S., M. Taketomi, M. Nakajima, M. Kitazawa, H. Shimada, S. Itoh, M. Igarashi, N. Higashikuni, S. Sutou & Y.E. Sasaki: Effect of aging on spontaneous micronucleus frequencies in peripheral blood of nine mouse strains. Mutat Res 338, 51-57 (1995)
239. Dolle M.E.T., H. Giese, C.L. Hopkins, H.J. Martus, J.M. Hausdorff & J. Vijg: Rapid accumulation of genome rearrangements in liverbut not in brain of old mice. Nature Genet 17, 431-434 (1997)
240. Dolle M.E.T., W.K. Snyder, J.A. Gossen, P.H.M. Lohman & J. Vijg: Distinct spectra of somatic mutations accumulated with age in mouse heart and small intestine. Proc Natl Acad Sci USA 97, 8403-8408 (2000)
241. Ono T., H. Ikehata, S. Nakamura, Y. Saito, Y. Hosi, Y. Takai, S. Yamada, J. Onodera & K. Jamamoto: Age-associated increase of spontaneous mutant frequency and molecular nature of mutation in newborn and old lacZ-transgenic mouse. Mutat Res 447, 165-177 (2000)
242. Stuart G.R., Y. Oda, J.G. de Boer & B.W. Glickman: Mutation frequency and specificity with age in liver, bladder and brain of Lac1 transgenic mice. Genetics 154, 1291-1300 (2000)
243. Rinehart C.A. & V.R. Torti: Aging and cancer: The role of stromal interactions with epithelial cells. Mol Carcinogenesis 18, 187-192 (1997)
244. Wright W.E. & J.W. Shay: Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nature Med 6, 849-851 (2000)
245. Wright W.E. & J.W. Shay: Historical claims and current interpretations of replicative aging. Nat Biotechnol 20, 682-688 (2002)
246. Vainio H., P. Magee, D. McGregor, A.J. McMichael, Eds: Mechanisms of Carcinogenesis in Risk Identification. IARC Sci Publ 116, IARC, Lyon, France (1992)